| Metric | Q2 2025 | Q2 2025 Estimate | Q2 2024 | Y/Y Change | | --- | --- | --- | --- | --- | | EPS (Non-GAAP) | $0.40 | $(0.01) | N/A | N/A | | Revenue (GAAP) | $39.6 million | $40.93 million | $40.4 million | (2.0%) | | Adjusted EBITDA (Non-GAAP) | $4.9 million | | $4.4 million | 11.4% | | GAAP Gross Margin | 40.5% | | 41.8% | (1.3 pp) | | Adjusted EBITDA Margin (Non-GAAP) | 12.4% | | 10.8% | 1.6 pp | Business Overview and Strategic Focus MariMed is a vertically integrated cannabis operator with branded ...

All-Natural Line of Wellness Products Designed to Support Overall Well-Being Now Available in MassachusettsNORWOOD, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), the company behind the award-winning flower and concentrate brand, Nature’s Heritage™, continued to drive innovation with the launch of MycroDose by Nature’s Heritage, a vegan line of all-natural wellness products that combine the power of full-spectrum cannabis with the added benefits of functional mus ...